{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-087359","form_type":"8-K","ticker":null,"cik":"0001673772","company_name":"RAPT Therapeutics, Inc.","filed_at":"2025-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.293917+00:00","generated_at":"2026-05-19T04:42:11.202546+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"RAPT Therapeutics effects 1-for-8 reverse stock split; post-split shares ~16.5M","bullets":["Stockholders approved reverse split at May 29, 2025 annual meeting.","Effective June 16, 2025, RAPT effected a 1-for-8 reverse stock split.","Post-split shares outstanding approx. 16.5 million (before eliminating fractional shares).","Certificate of Amendment filed with Delaware on June 13, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-087359","json":"https://secwatch.observer/filing/0000950170-25-087359.json","markdown":"https://secwatch.observer/filing/0000950170-25-087359.md","text":"https://secwatch.observer/filing/0000950170-25-087359.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1673772/000095017025087359/0000950170-25-087359-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1673772/000095017025087359/rapt-20250613.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T04:42:11.202546+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cbe5c1dbe930d343d095dcee940e10c392cf7531","claim":"RAPT Therapeutics, Inc.: Effected a 1-for-8 reverse stock split of common stock via Certificate of Amendment to the Amended and Restated Certificate of Incorporation (effective 2025-06-16).","evidence_excerpt":"Effective June 16, 2025 at 11:59 p.m. Eastern Time, the Company effected a 1-for-8 reverse stock split pursuant to a Certificate of Amendment (the “Certificate of Amendment”) to the Company’s Amended and Restated Certificate of Incorporation filed with the Secretary of State of the State of Delaware on June 13, 2025.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1673772/000095017025087359/0000950170-25-087359-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-06-16"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}